Wednesday, May 25, 2022

TOPICS

Home Tags U.S. Food and Drug Administration

Tag: U.S. Food and Drug Administration

FDA OKs another Pfizer, Moderna COVID booster for 50 and older

U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable...

Pfizer vaccine for kids may not be available until November

WASHINGTON (AP)– Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the...
IN GOOD HANDS: Jennifer Beaugh, right, pharmacy supervisor at The Miriam Hospital, hands a dose of COVID-19 vaccine to Dr. Karen Tashima at a clinic at The Miriam. Tashima is overseeing a clinical trial of the COVID-19 vaccine that hasn’t yet received U.S. government approval.  / COURTESY LIFESPAN CORP.

R.I. plays role in making new COVID-19 vaccines

What seemed like an epic race for an effective COVID-19 vaccine has produced several options that have people rolling up their sleeves across Rhode...

R.I. pauses administration of Johnson & Johnson vaccine, citing federal recommendation

PROVIDENCE – The R.I. Department of Health paused administration of the Johnson & Johnson vaccine this morning, following on a recommendation to states from...
CLOSE EYE: From left, associate manufacturer Adeline Lamothe, manufacturing process technician contract worker Austin White and associate manufacturer David Folco check the single-use bioreactors, which are used to control the conditions for generating protein cells at Amgen Rhode Island in West Greenwich. / COURTESY AMGEN INC.

Team approach allows Amgen to complete new biomanufacturing plant in 2020

PBN Manufacturing Awards 2021 Overall Excellence at an Enterprise Manufacturer: Amgen Rhode Island Amgen Inc. develops medications for oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and...
PHARMACIST ASSIST: Jeanine Sinanan-Singh, co-founder and CEO of Vitae Industries Inc. in Providence, says the company’s AutoCompounder, which allows pharmacists to mix ingredients to create the proper dose of medication for an individual patient, was the first product of its kind to market. / PBN PHOTO/TRACY JENKINS

Vitae’s AutoCompounder increasing efficiencies in personalized meds for pharmacies

PBN Manufacturing Awards 2021 Emerging Manufacturer: Vitae Industries Inc. Vitae Industries Inc. works to promote efficiency in pharmacies with the assistance of its AutoCompounder product. Drug compounding...

R.I. approves vaccine, first doses distributed to hospitals

PROVIDENCE – A portion of Rhode Island's frontline health care workers were set to receive the first federally approved COVID-19 vaccine Monday. The Rhode Island...

Residents, staff at nearly 200 R.I. long-term care facilities to get...

PROVIDENCE – Residents and staff members at nursing homes will be among the first people in Rhode Island to receive the coronavirus vaccine. The state...
RHODE ISLAND officials say the first delivery of nearly 10,000 doses of the Pfizer-BioNTech COVID-19 vaccine and approximately 19,000 doses of the Moderna vaccine could arrive in Rhode Island soon. / AP FILE PHOTO/HANS PENNINK

R.I. outlines COVID-19 vaccination strategy, but some unknowns remain

PROVIDENCE – As Rhode Island continues to get pummeled by the COVID-19 pandemic – with cases overwhelming hospital systems and shuttering businesses – state...

Subsalve USA LLC

THE STORY: For close to 40 years, Subsalve USA LLC has worked to keep people and vessels above water. The North Kingstown-based manufacturer specializes...

Stay up to date with PBN's Morning Call & Daily Edition newsletters.

- Featured Event -

Latest News

SPRING SALE

CLOSE

50% off for one day only

Hurry, this offer ends in:

00
Months
00
Days
00
Hours
00
Minutes
00
Seconds

Sign-up to get the

PBN Daily Edition

A collection of all the published news of the last 24 hours, as well as selected features from PBN’s weekly print edition.

By submitting the form you agree to PBN's Privacy Policy and Terms of Use.

Exit Intent

PBN is becoming a habit.
You've exceeded our free article limit for the month. Keep reading this article with a subscription to PBN.

Keep reading this subscriber-only article

with a subscription to PBN.

ALREADY A SUBSCRIBER? LOG IN

Register to keep reading or subscribe today to get unlimited access now.

ALREADY A SUBSCRIBER? LOG IN

ANNUAL SALE

CLOSE

70% off for one day only

Hurry, this offer ends in:

00
Months
00
Days
00
Hours
00
Minutes
00
Seconds

Register to read all articles free - This week only!

CLOSE

One week only, get full access to all articles on PBN.com when you create a complimentary account.

One week only, get full access to all articles on PBN.com when you create a complimentary account.

 

Register today >>